X0202 4 2007-10-04 0 0001318310 ev3 Inc. evvv 0001007708 SIMPSON JOHN B PH D MD C/O EV3 INC. 9600 54TH AVENUE NORTH, SUITE 100 PLYMOUTH MN 55442 1 1 0 0 Vice Chair & Chief Scientist Common Stock 2007-10-04 4 A 0 5808172 A 5808172 I By Simpson Family Trust Common Stock 2007-10-04 4 A 0 716285 A 716285 I by JD Simpson Trust No. 2 Common Stock 2007-10-04 4 A 0 262062 A 262062 I By Fox Hollow, L.P. Common Stock 2007-10-04 4 A 0 293617 A 293617 I by John Bush Simpson Annuity Trust Common Stock 2007-10-04 4 A 0 293617 A 293617 I by Rita Lynn Simpson Annuity Trust Common Stock 2007-10-04 4 A 0 291780 A 291780 I by John Bush Simpson Annuity Trust 3 Common Stock 2007-10-04 4 A 0 291780 A 291780 I by Rita Lynn Simpson Annuity Trust 3 Common Stock 2007-10-04 4 A 0 48183 A 48183 I By Spouse Common Stock 2007-10-04 4 A 0 484 A 484 D Common Stock 2007-10-04 4 A 0 16447 0 A 16447 D Employee Stock Option (right to buy) 12.94 2007-10-04 4 A 0 80900 A 2017-04-10 Common Stock 80900 80900 D Restricted Stock Units with Performance Based Vesting 0 2007-10-04 4 A 0 40450 A Common Stock 40450 40450 D Employee Stock Option (right to buy) 16.64 2007-10-04 4 A 0 37500 0 A 2017-10-04 Common Stock 37500 37500 D Received in exhcnage for 4,005,636 shares of FoxHollow Technologies, Inc. ("FoxHollow") common stock in connection with the merger of a wholly-owned subsidiary of ev3 Inc. ("ev3") with and into FoxHollow (the "Merger"). Each shares of the reporting person's FoxHollow shares was exchanged for 1.45 shares of ev3 common stock and $2.75 per share in cash without interest in connetion with the Merger (the "Merger Consideration"). These shares are held by the Simpson Family Trust, of which Dr. Simpson serves as a trustee. Dr. Simpson disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Received in exchange for 493,990 shares of FoxHollow common stock in connection with the Merger. Each share of the reporting person's FoxHollow shares was exchagned for the Merger Consideration. These shares are held by the JD Simpson Trust No. 2, of which Dr. Simpson serves as a trustee. The shares are held in a trust for the benefit of Dr. Simpson's son, of which Dr. Simpson serves as a trustee. Dr. Simpson disclaims beneficial ownership of these shares, and the filing of this report is not an admission that Dr. Simpson is a beneficial owner of these shares for purposes of Section 16 or for any other purpose. Received in exchange for 180,733 shares of FoxHollow common stock in connection with the Merger. Each share of the reporting person's FoxHollow shares was exchanged for the Merger Consideration. These shares are held by FoxHollow, L.P., a California Limited Partnership, of which Dr. Simpson serves as a managing member. Dr. Simpson disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Received in exchange for 202,495 shares of FoxHollow common stock in connection with the Merger. Each share of the reporting person's FoxHollow shares was exchanged for the Merger Consideration. Received in exchange for 201,228 shares of FoxHollow common stock in connection with the Merger. Each share of the reporting person's FoxHollow shares was exchanged for the Merger Consideration. Received in exchange for 33,230 shares of FoxHollow common stock in connection with the Merger. Each share of the reporting person's FoxHollow shares was exchanged for the Merger Consideration. Received in exchange for 334 shares of FoxHollow common stock in connection with the Merger. Each share of the reporting person's FoxHollow shares was exchanged for the Merger Consideration. These shares were issued pursuant to a restricted stock grant under the ev3 Inc. Amended and Restated 2005 Stock Incentive Plan, such shares vest over time and are subject to forfeiture until vested. This option becomes exercisable as to 1/2 of the shares on March 6, 2008 and 1/24 of the remaining shares vest and become exercisable each month thereafter for 24 months. Received in the Merger in exchange for an employee stock option to acquire 50,000 shares of FoxHollow common stock for an exercise price of $20.94 per share. The restricted stock unit will vest with respect to 50% of the unvested shares on October 4, 2007 and with respect to the remaining unvested shares on October 4, 2008. Received in the Merger in exchange for a restricted stock unit to acquire 41,250 shares of FoxHollow common stock. This option becomes exercisable as to 1/4 of the shares on October 4, 2008 and 1/36 of the remaining shares vest and become exercisable each month thereafter for 36 months. /s/ John B. Simpson, Ph.D. 2007-10-09